MT-TP and metabolic dysfunction-associated steatotic liver disease: This study, focusing on common polymorphisms over promoter (-493G/T) and N-terminal β-barrel (residues 22-297) of MTTP, was tried to estimate and compare the genetic impact on serum lipids and NAFLD, adjusted by the above metabolic regulators.